FIELD: biotechnology.
SUBSTANCE: described is a method for indirect determination of the number of colony-forming units of Mycoplasma arginini using quantitative hybridization-fluorescence detection and quantitative assessment cycle of amplification reaction. CFU value of Mycoplasma arginini is determined by the value of the quantitative assessment cycle. Based on the established value of this indicator, the CFU value of the given pathogen is calculated.
EFFECT: proposed invention enables to quickly and with a high degree of reliability calculate the titre of infectious activity of Mycoplasma arginini in the analyzed material by using specific oligonucleotide primers and a molecular probe for a portion of the regE gene of Mycoplasma arginini and a developed logarithmic model.
2 cl, 2 dwg, 5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MEDIATED DETERMINATION OF TITRE OF INFECTIOUS ACTIVITY OF MYCOPLASMA GALLISEPTICUM BY PCR IN REAL TIME MODE | 2023 |
|
RU2823778C1 |
| METHOD FOR INDIRECT DETERMINATION OF FELINE CALICIVIRUS INFECTIOUS ACTIVITY TITRE IN NON-INACTIVATED RAW MATERIAL FOR CULTURAL VACCINES BY MEANS OF QUANTITATIVE REGISTRATION OF REACTION OF AMPLIFICATION OF ORF1-GENE SECTION OF VIRAL RNA | 2023 |
|
RU2821027C1 |
| METHOD OF INDIRECTLY DETERMINING TITER OF INFECTIOUS ACTIVITY OF CANINE INFECTIOUS HEPATITIS VIRUS GENOTYPE CAV-1 IN RAW MATERIALS FOR CULTURED VACCINES USING REAL-TIME POLYMERASE CHAIN REACTION USING QUANTITATIVE ASSESSMENT CYCLE Cq | 2023 |
|
RU2812441C1 |
| METHOD OF INDIRECT DETERMINATION OF TITER OF INFECTIOUS ACTIVITY OF CAUSATIVE AGENT OF INFECTIOUS FELINE RHINOTRACHEITIS FHV IN NON-INACTIVATED RAW MATERIALS FOR VACCINES USING POLYMERASE CHAIN REACTION AND QUANTITATIVE HYBRIDIZATION-FLUORESCENCE DETECTION IN REAL TIME | 2023 |
|
RU2808641C1 |
| METHOD FOR INDIRECT DETERMINATION OF TITER OF INFECTIOUS ACTIVITY OF CANINE MASTADENOVIRUS IN RAW MATERIALS FOR VACCINES USING REAL-TIME PCR | 2023 |
|
RU2808585C1 |
| METHOD FOR THE INDIRECT DETERMINATION OF THE CONCENTRATION OF THE IMMUNOGENIC RNP COMPLEX OF RABIES VIRUS IN RAW MATERIALS FOR RABIES VACCINES BY AMPLIFICATION AND HYBRIDIZATION-FLUORESCENT DETECTION OF DNA AMPLICONS | 2020 |
|
RU2760436C1 |
| METHOD OF INDIRECT DETERMINING OF TITRE OF INFECTIOUS ACTIVITY OF CAUSATIVE AGENT OF CANINE DISTEMPER IN RAW MATERIALS FOR VACCINES USING METHOD OF REVERSE TRANSCRIPTION AND AMPLIFICATION REACTION IN REAL TIME | 2023 |
|
RU2815533C1 |
| METHOD FOR MEDIATED DETERMINATION OF THE INFECTIOUS TITER OF THE RABIES VIRUS IN NON-INACTIVATED RAW MATERIALS FOR RABIES VACCINES IN TRANSCRIPTIONAL AMPLIFICATION AND DETECTION OF REACTION PRODUCTS USING THE BEACON TECHNOLOGY | 2020 |
|
RU2756472C1 |
| METHOD OF INDIRECT DETERMINATION OF TITER OF INFECTIOUS ACTIVITY OF CANINE MASTADENOVIRUS IN RAW MATERIALS FOR VACCINES USING REAL-TIME PCR | 2023 |
|
RU2812858C1 |
| METHOD FOR DETERMINING TITRE OF INFECTIOUS ACTIVITY OF CANINE DISTEMPER AGENT IN RAW MATERIAL FOR MAKING CULTURE INACTIVATED VACCINES | 2024 |
|
RU2831062C1 |
